↓ Skip to main content

Dove Medical Press

Subcutaneous immunoglobulin replacement therapy in the treatment of patients with primary immunodeficiency disease

Overview of attention for article published in Therapeutics and Clinical Risk Management, December 2009
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (83rd percentile)
  • Good Attention Score compared to outputs of the same age and source (70th percentile)

Mentioned by

twitter
1 X user
patent
3 patents
wikipedia
1 Wikipedia page

Readers on

mendeley
46 Mendeley
Title
Subcutaneous immunoglobulin replacement therapy in the treatment of patients with primary immunodeficiency disease
Published in
Therapeutics and Clinical Risk Management, December 2009
DOI 10.2147/tcrm.s4353
Authors

Hans Ochs

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 46 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 1 2%
Unknown 45 98%

Demographic breakdown

Readers by professional status Count As %
Researcher 9 20%
Other 8 17%
Student > Ph. D. Student 5 11%
Student > Postgraduate 3 7%
Student > Bachelor 2 4%
Other 9 20%
Unknown 10 22%
Readers by discipline Count As %
Medicine and Dentistry 24 52%
Agricultural and Biological Sciences 5 11%
Nursing and Health Professions 2 4%
Psychology 2 4%
Immunology and Microbiology 1 2%
Other 4 9%
Unknown 8 17%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 7. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 26 July 2023.
All research outputs
#5,343,131
of 25,392,582 outputs
Outputs from Therapeutics and Clinical Risk Management
#266
of 1,323 outputs
Outputs of similar age
#28,446
of 177,065 outputs
Outputs of similar age from Therapeutics and Clinical Risk Management
#3
of 10 outputs
Altmetric has tracked 25,392,582 research outputs across all sources so far. Compared to these this one has done well and is in the 78th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,323 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 9.6. This one has done well, scoring higher than 79% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 177,065 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 83% of its contemporaries.
We're also able to compare this research output to 10 others from the same source and published within six weeks on either side of this one. This one has scored higher than 7 of them.